Mercer Capital Advisers’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Mercer Capital Advisers’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-300	Closed	-$22K	–	296
2015 Q3	$22K	Hold	300	–	–	0.02%	203
2015 Q2	$23K	Hold	300	–	–	0.02%	213
2015 Q1	$15K	Hold	300	–	–	0.01%	233
2014 Q4	$10K	Buy	+300	New	+$10.5K	0.01%	254

Mercer Capital Advisers's KYTH Position: Q4 2015 in Review

Mercer Capital Advisers sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 300 shares — an estimated $22K sold.

Mercer Capital Advisers first reported a position in KYTH in Q4 2014 and held it in 4 quarters. The position peaked at $23K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Mercer Capital Advisers reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Mercer Capital Advisers sold 300 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $22K.
Mercer Capital Advisers first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2014 and held it in 4 quarters.
Mercer Capital Advisers's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $23K in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Mercer Capital Advisers's 13F filing for Q4 2015, filed 29 Jan 2016.